Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) Global Forecast to 2023
[340 Pages Report] The immunoassay market was valued at USD 19.01 Billion in 2017 and is expected to reach USD 27.15 Billion by 2023, at a CAGR of 6.1%. The base year for this study is 2017 and the forecast period is 20182023.
Market Dynamics
Drivers
Increasing adoption of immunoassay-based point-of-care testing and rapid testing
The immunoassay-based point-of-care (POC) testing and rapid testing industries have witnessed significant growth over the last few years owing to the increasing adoption of POC testing products in home care as well as in hospitals. Factors such as the rising prevalence of chronic and infectious diseases, technological advancements in POC testing products, and growing patient awareness of POC testing are some of the major factors driving the demand for immunoassay-based POC testing and rapid testing across the globe.
Immunoassay-based POC testing analyzers provide high sensitivity while ensuring patient compliance. Moreover, they reduce the turnaround time for the diagnosis and management of various diseases, such as HIV, malaria, dengue, tuberculosis, and hepatitis C. Due to such advantages, these products are increasingly being used to make informed clinical decisions for improved healthcare outcomes. Moreover, government initiatives to support the adoption of POC testing and rapid testing are expected to further drive the growth of these segments. For instance, in March 2016, the Department of Biotechnology (India) created an India-focused fund, which will be a part of the Longitude Prizes Discovery Award Program. Through this program, innovators in India will be awarded USD 14.5 million for developing a rapid, easy, affordable, and accurate point-of-care diagnostic test for conserving antibiotics.
Restraints
Unfavorable reimbursement scenario
Inadequate reimbursement is a major factor restraining the growth of the immunoassay market. In the US, Medicare revised its reimbursement mechanism for some IVD tests, including immunoassays and molecular tests, in 2012. Some of these molecular pathology tests do not have their own Healthcare Common Procedure Coding System (HCPCS) codes and are instead billed using unlisted codes. In such cases, Medicare Administrative Contractors (MACs) establish a payment amount for their local jurisdictions. According to the CMS, ~75% of tests showed reductions in reimbursement rates from January 2017. Some of these tests include molecular tests, targeted NGS analysis panels of five to 50 genes, and cancer tests. These developments are expected to adversely affect the US molecular and genetic testing market, which, in turn, will restrain the growth of the immunoassay market.
According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years. This, along with budgetary considerations among healthcare systems, will act as a major obstacle for the implementation of novel diagnostic techniques in clinical laboratories, as the reimbursements for these tests are low.
Opportunities
Increasing importance of companion diagnostics in the immunoassay market
Companion diagnostics include tests or assays intended to assist healthcare providers in making treatment decisions for patients based on the best response to therapy. The co-development of companion diagnostics with therapeutic products has the potential to significantly alter the drug development process and commercialize drug candidates by yielding safer drugs with enhanced therapeutic efficacy quickly and cost-effectively. With an increase in the demand for high-priced specialist therapies and safer drugs, the market for companion diagnostics is expected to showcase a high growth potential. The growing
The objectives of this study are as follows:
- To define, describe, segment, and forecast the market by product & service, technology, platform, specimen type, application, end user, and region
- To forecast the revenue of the market segments of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, and opportunities affecting the growth of the market
- To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as partnerships, agreements, collaborations; mergers and acquisitions; product launches; and research and development activities in the market
Research Methodology
Top-down and bottom-up approaches were used to estimate and validate the size of the global immunoassay industry and to estimate the size of dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product & service, technology, platform, specimen type, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as American Association of Immunologists (AAI), National Center for Biotechnology Information (NCBI), American Medical Association (AMA), American Autoimmune Related Diseases Association (AARDA), Association of Medical School Microbiology and Immunology Chairs (AMSMIC), Society for Immunotherapy of Cancer (SITC), Canadian Society for Immunology (CSI), German Institute of Medical Documentation and Information (DIMDI), Association of Medical Diagnostics Manufacturers (AMDM), British In Vitro Diagnostics Association (BIVDA), European Diagnostic Manufacturers Association (EDMA), Spanish Society for Immunology, British Society for Allergy & Clinical Immunology (BSACI), Chinese Society of Immunology (CSI), China Association of In-Vitro Diagnostics (CAIVD), China Association for Medical Devices Industry (CAMDI) and many others, have been used to identify and collect information useful for this extensive commercial study of the immunoassay market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information and to assess prospects of the market. The breakdown of profiles of primaries is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
The key players in the immunoassay market include Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMιrieux (France), Ortho Clinical Diagnostics (US), DiaSorin (Italy), QIAGEN (Netherlands), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Quidel Corporation (US), Bio-Techne Corporation (US), and Mindray (China).
Target Audience for this Report:
- Manufacturers and vendors of immunoassay instruments and consumables
- In Vitro Diagnostic (IVD) product manufacturers
- Pharmaceutical and biopharmaceutical players
- Diagnostic associations
- Research associations involved in infectious and chronic diseases research
- Various research and consulting firms
- Distributors of immunoassays instruments and consumables
- Contract research manufacturers of immunoassays
- Healthcare institutions
- Research institutes
Scope of the Report:
This report categorizes the market into the following segments:
By Product & Service
- Reagents & Kits
- Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
- Rapid Test Reagents and Kits
- Enzyme-linked Immunospot ELISPOT Reagents and Kits
- Western Blot Reagents and Kits
- Other Reagents & Kits
- Analyzers
- By Type
- Open-ended Systems
- Closed-ended systems
- By Purchase Mode
- Rental Purchase
- Outright Purchase
- By Type
- Software & Services
By Platform
- Chemiluminescence Immunoassays (CLIAs)
- Fluorescence Immunoassays (FIAs)
- Colorimetric Immunoassays (CIs)
- Radioimmunoassays (RIAs)
- Other Platforms
By Technology
- ELISA
- First-generation
- Second-generation
- Third-generation
- Fourth-generation & Above
- Rapid Tests
- Western Blotting
- ELISPOT
- Immuno-PCR
- Other Technologies
By Specimen
- Blood
- Saliva
- Urine
- Other Specimens
By Application
- Infectious Diseases
- Endocrinology
- Oncology
- Bone & Mineral Disorders
- Cardiology
- Hematology & Blood Screening
- Autoimmune Disorders
- Toxicology
- Neonatal Screening
- Other Applications
By End User
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs)
- Blood Banks
- Research & Academic Laboratories
- Other End Users
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Indonesia
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Customization Options:
- Company Information: Detailed company profiles of five or more market players
- Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market
The global immunoassay market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments.
The global market is segmented by product and service, platform, technology, specimen type, application, end user, and region. By product and service, the market is segmented into reagents and kits, analyzers, and software & services. The immunoassay reagents and kits segment accounted for the largest share of this market in 2017. The large share of this segment can primarily be attributed to the requirement of the repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.
By platform, the market is segmented into chemiluminescence immunoassays (CLIAs), colorimetric immunoassays (CIs), fluorescence immunoassays (FIAs), radioimmunoassays (RIAs), and other platforms. The CLIAs segment accounted for the largest share of the immunoassay market in 2017. The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based tests.
On the basis of technology, the market is segmented into enzyme-linked immunosorbent assays (ELISA), rapid tests, western blotting, enzyme-linked immunospot (ELISPOT), immuno-PCR, and other technologies. The ELISA segment accounted for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increasing use of immunoassay tests in cancer, infectious diseases, and therapeutic drug level monitoring.
By specimen type, the market is segmented into blood, urine, saliva, and other specimens. In 2017, the blood samples segment accounted for the largest share of the market. Moreover, this segment is projected to register the highest CAGR during the forecast period, primarily due to the increasing number of blood donations and the rising incidence of chronic and infectious diseases across the globe.
By application, the market is classified into infectious diseases, endocrinology, bone and mineral disorders, oncology, cardiology, hematology and blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications. In 2017, the infectious diseases segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing incidence of infectious diseases and the rising number of product approvals in this segment.
On the basis of end users, the market is segmented into hospitals, clinical laboratories, blood banks, research and academic laboratories, pharmaceutical and biotechnology companies and contract research organizations (CROs), and other end users. The hospitals segment accounted for the largest share of the immunoassay market in 2017. The large share of this segment is primarily attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories due to easy access to reports and smooth logistics. Additionally, these laboratories also work as reference laboratories to small hospitals and physician offices.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the market. The availability of government funds, growing use of immunoassays in clinical diagnostics, and the presence of key players in the region are driving the market in North America.
The factors such as the high degree of consolidation and a complex regulatory framework for the approval of new products may restrain market growth to a certain extent.
Major industry players adopted product launches and partnerships, collaborations, & agreements to maintain and improve their position in the immunoassay market. Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), and Danaher Corporation (US) have been identified as key players in this market. These companies have a broad product portfolio with comprehensive features and have also expanded their presence geographically. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 23)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 27)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. - 35)
4 Premium Insights (Page No. - 42)
4.1 Immunoassays: Market Overview
4.2 Asia Pacific: Immunoassays Market, By Platform (2017)
4.3 Market, By Product & Service (20182023)
4.4 Geographical Snapshot of the Market
5 Market Overview (Page No. - 46)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Chronic and Infectious Diseases
5.2.1.1.1 Increasing Use of Immunoassays in Oncology
5.2.1.1.2 Growing Geriatric Population
5.2.1.2 Technological Advancements in Immunoassay Instruments and Introduction of Novel Automated Systems
5.2.1.3 Growth in the Biotechnology and Biopharmaceutical Industries
5.2.1.4 Increasing Adoption of Immunoassay-Based Point-Of-Care Testing and Rapid Testing
5.2.1.5 Vital Role of Immunoassays in Drug and Alcohol Testing
5.2.1.5.1 Growing Drug and Alcohol Consumption
5.2.1.5.2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Requirements for the Approval of Immunoassay Instruments and Consumables
5.2.2.2 Implementation of Excise Duty on the Sale of Medical Devices in the Us
5.2.2.3 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Economies
5.2.3.2 Increasing Importance of Companion Diagnostics in the Immunoassay Market
5.2.3.3 Development of Condition-Specific Biomarkers and Tests
5.2.3.4 Integration of Microfluidics Technology in Immunoassays
5.2.4 Challenges
5.2.4.1 Complexities in Conducting Diagnostic Tests
6 Immunoassay Market, By Product & Service (Page No. - 60)
6.1 Introduction
6.2 Reagents & Kits
6.2.1 Reagents & Kits Market, By Type
6.2.1.1 Elisa Reagents & Kits
6.2.1.2 Rapid Test Reagents & Kits
6.2.1.3 Elispot Reagents & Kits
6.2.1.4 Western Blot Reagents & Kits
6.2.1.5 Other Reagents & Kits
6.3 Analyzers
6.3.1 Immunoassay Analyzers Market, By Type
6.3.1.1 Open-Ended Systems
6.3.1.2 Closed-Ended Systems
6.3.2 Immunoassay Analyzers Market, By Purchase Mode
6.3.2.1 Rental Purchase
6.3.2.2 Outright Purchase
6.4 Software & Services
7 Immunoassay Market, By Platform (Page No. - 77)
7.1 Introduction
7.2 Chemiluminescence Immunoassays
7.3 Fluorescence Immunoassays
7.4 Colorimetric Immunoassays
7.5 Radioimmunoassays
7.6 Other Platforms
8 Immunoassay Market, By Technology (Page No. - 85)
8.1 Introduction
8.2 Enzyme-Linked Immunosorbent Assays
8.2.1 Elisa Market, By Generation
8.2.1.1 First-Generation Elisa
8.2.1.2 Second-Generation Elisa
8.2.1.3 Third-Generation Elisa
8.2.1.4 Fourth-Generation & Above Elisa
8.3 Rapid Tests
8.4 Enzyme-Linked Immunospot
8.5 Western Blotting
8.6 Immuno-Pcr
8.7 Other Technologies
9 Immunoassay Market, By Specimen Type (Page No. - 100)
9.1 Introduction
9.2 Blood
9.3 Saliva
9.4 Urine
9.5 Other Specimens
10 Immunoassay Market, By Application (Page No. - 106)
10.1 Introduction
10.2 Infectious Diseases
10.3 Endocrinology
10.4 Oncology
10.5 Bone & Mineral Disorders
10.6 Cardiology
10.7 Hematology & Blood Screening
10.8 Autoimmune Disorders
10.9 Toxicology
10.10 Neonatal Screening
10.11 Other Applications
11 Immunoassay Market, By End User (Page No. - 121)
11.1 Introduction
11.2 Hospitals
11.3 Clinical Laboratories
11.4 Pharmaceutical and Biotechnology Companies & Cros
11.5 Blood Banks
11.6 Research & Academic Laboratories
11.7 Other End Users
12 Global Immunoassay Market, By Region (Page No. - 131)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 Italy
12.3.3 France
12.3.4 Spain
12.3.5 UK
12.3.6 Russia
12.3.7 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Indonesia
12.4.7 Rest of Asia Pacific
12.5 Latin America
12.6 Middle East & Africa
13 Competitive Landscape (Page No. - 266)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Situation and Trends
13.3.1 Product Launches
13.3.2 Partnerships, Collaborations, and Agreements
13.3.3 Expansions
13.3.4 Acquisitions
14 Company Profiles (Page No. - 271)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
14.1 Roche
14.2 Abbott Laboratories
14.3 Siemens
14.4 Danaher
14.5 Diasorin
14.6 Sysmex
14.7 Biomιrieux
14.8 Ortho Clinical Diagnostics
14.9 Qiagen
14.10 Thermo Fisher Scientific
14.11 Becton, Dickinson & Company
14.12 Bio-Rad Laboratories
14.13 Agilent Technologies
14.14 Mindray
14.15 Perkinelmer
14.16 Quidel
14.17 Merck
14.18 Bio-Techne
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
15 Appendix (Page No. - 330)
15.1 Industry Insights
15.2 Discussion Guide
15.3 Knowledge Store: Marketsandmarkets Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Available Customizations
15.6 Related Reports
15.7 Author Details
List of Tables (293 Tables)
Table 1 Global Incidence of Infectious Diseases in 2015
Table 2 Global Incidence of the Top 10 Cancers (2012, 2015, & 2035)
Table 3 Detection of Drugs By Urine Testing
Table 4 New Tests Launched By Key Players
Table 5 Immunoassay Market, By Product & Service, 20162023 (USD Million)
Table 6 Immunoassay Reagents & Kits Market, By Region, 20162023 (USD Million)
Table 7 Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 8 Elisa Reagents & Kits Market, By Region, 20162023 (USD Million)
Table 9 Rapid Test Reagents & Kits Market, By Region, 20162023 (USD Million)
Table 10 Elispot Reagents & Kits Market, By Region, 20162023 (USD Million)
Table 11 Western Blot Reagents & Kits Market, By Region, 20162023 (USD Million)
Table 12 Other Reagents & Kits Market, By Region, 20162023 (USD Million)
Table 13 Immunoassay Analyzers Market, By Region, 20162023 (USD Million)
Table 14 Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 15 Open-Ended Systems Market, By Region, 20162023 (USD Million)
Table 16 Closed-Ended Systems Market, By Region, 20162023 (USD Million)
Table 17 Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 18 Immunoassay Analyzers Rental Purchase Market, By Region, 20162023 (USD Million)
Table 19 Immunoassay Analyzers Outright Purchase Market, By Region, 20162023 (USD Million)
Table 20 Immunoassay Software & Services Market, By Region, 20162023 (USD Million)
Table 21 Immunoassay Market, By Platform, 20162023 (USD Million)
Table 22 Clia Systems Available in the Market
Table 23 Chemiluminescence Market, By Region, 20162023 (USD Million)
Table 24 Fluorescence Market, By Region, 20162023 (USD Million)
Table 25 Colorimetric Market, By Region, 20162023 (USD Million)
Table 26 Radioimmunoassay Market, By Region, 20162023 (USD Million)
Table 27 Other Platforms Market, By Region, 20162023 (USD Million)
Table 28 Market, By Technology, 20162023 (USD Million)
Table 29 Key Elisa Systems Available in the Market
Table 30 Elisa Market, By Region, 20162023 (USD Million)
Table 31 Elisa Market, By Generation, 20162023 (USD Million)
Table 32 First-Generation Elisa Market, By Region, 20162023 (USD Million)
Table 33 Second-Generation Elisa Market, By Region, 20162023 (USD Million)
Table 34 Third-Generation Elisa Market, By Region, 20162023 (USD Million)
Table 35 Fourth-Generation & Above Elisa Market, By Region, 20162023 (USD Million)
Table 36 Key Rapid Tests Available in the Market
Table 37 Rapid Tests Market, By Region, 20162023 (USD Million)
Table 38 Elispot Market, By Region, 20162023 (USD Million)
Table 39 Western Blotting Systems Available in the Market
Table 40 Western Blotting Market, By Region, 20162023 (USD Million)
Table 41 Immuno-Pcr Market, By Region, 20162023 (USD Million)
Table 42 Other Immunoassay Technologies Market, By Region, 20162023 (USD Million)
Table 43 Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 44 Market for Blood Samples, By Region, 20162023 (USD Million)
Table 45 Market for Saliva Samples, By Region, 20162023 (USD Million)
Table 46 Market for Urine Samples, By Region, 20162023 (USD Million)
Table 47 Market for Other Specimens, By Region, 20162023 (USD Million)
Table 48 Immunoassay Market, By Application, 20162023 (USD Million)
Table 49 Market for Endocrinology, By Region, 20162023 (USD Million)
Table 51 Market for Oncology, By Region, 20162023 (USD Million)
Table 52 Market for Bone & Mineral Disorders, By Region, 20162023 (USD Million)
Table 53 Immunoassay Market for Cardiology, By Region, 20162023 (USD Million)
Table 54 Market for Hematology & Blood Screening, By Region, 20162023 (USD Million)
Table 55 Market for Autoimmune Disorders, By Region, 20162023 (USD Million)
Table 56 Market for Toxicology, By Region, 20162023 (USD Million)
Table 57 Immunoassay Market for Neonatal Screening, By Region, 20162023 (USD Million)
Table 58 Market for Other Applications, By Region, 20162023 (USD Million)
Table 59 Market, By End User, 20162023 (USD Million)
Table 60 Market for Hospitals, By Region, 20162023 (USD Million)
Table 61 Market for Clinical Laboratories, By Region, 20162023 (USD Million)
Table 62 Market for Pharmaceutical and Biotechnology Companies and Cros, By Region, 20162023 (USD Million)
Table 63 Immunoassay Market for Blood Banks, By Region, 20162023 (USD Million)
Table 64 Market for Research & Academic Laboratories, By Region, 20162023 (USD Million)
Table 65 Market for Other End Users, By Region, 20162023 (USD Million)
Table 66 Market, By Region, 20162023 (USD Million)
Table 67 North America: Immunoassay Market, By Country, 20162023 (USD Million)
Table 68 North America: Market, By Product & Service, 20162023 (USD Million)
Table 69 North America: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 70 North America: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 71 North America: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 72 North America: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 73 North America: Elisa Market, By Generation, 20162023 (USD Million)
Table 74 North America: Market, By Platform, 20162023 (USD Million)
Table 75 North America: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 76 North America: Market, By Application, 20162023 (USD Million)
Table 77 North America: Market, By End User, 20162023 (USD Million)
Table 78 US: Market, By Product & Service, 20162023 (USD Million)
Table 79 US: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 80 US: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 81 US: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 82 US: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 83 US: Elisa Market, By Generation, 20162023 (USD Million)
Table 84 US: Market, By Platform, 20162023 (USD Million)
Table 85 US: Market, By Specimen Type, 20162023 (USD Million)
Table 86 US: Market, By Application, 20162023 (USD Million)
Table 87 US: Market, By End User, 20162023 (USD Million)
Table 88 Canada: Market, By Product & Service, 20162023 (USD Million)
Table 89 Canada: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 90 Canada: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 91 Canada: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 92 Canada: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 93 Canada: Elisa Market, By Generation, 20162023 (USD Million)
Table 94 Canada: Market, By Platform, 20162023 (USD Million)
Table 95 Canada: Market, By Specimen Type, 20162023 (USD Million)
Table 96 Canada: Market, By Application, 20162023 (USD Million)
Table 97 Canada: Immunoassay Market, By End User, 20162023 (USD Million)
Table 98 Mexico: Market, By Product & Service, 20162023 (USD Million)
Table 99 Mexico: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 100 Mexico: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 101 Mexico: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 102 Mexico: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 103 Mexico: Elisa Market, By Generation, 20162023 (USD Million)
Table 104 Mexico: Market, By Platform, 20162023 (USD Million)
Table 105 Mexico: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 106 Mexico: Market, By Application, 20162023 (USD Million)
Table 107 Mexico: Market, By End User, 20162023 (USD Million)
Table 108 Europe: Market, By Country, 20162023 (USD Million)
Table 109 Europe: Market, By Product & Service, 20162023 (USD Million)
Table 110 Europe: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 111 Europe: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 112 Europe: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 113 Europe: Market, By Technology, 20162023 (USD Million)
Table 114 Europe: Elisa Market, By Generation, 20162023 (USD Million)
Table 115 Europe: Immunoassay Market, By Platform, 20162023 (USD Million)
Table 116 Europe: Market, By Specimen Type, 20162023 (USD Million)
Table 117 Europe: Market, By Application, 20162023 (USD Million)
Table 118 Europe: Immunoassay Market, By End User, 20162023 (USD Million)
Table 119 Germany: Market, By Product & Service, 20162023 (USD Million)
Table 120 Germany: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 121 Germany: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 122 Germany: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 123 Germany: Immunoassays Market, By Technology, 20162023 (USD Million)
Table 124 Germany: Elisa Market, By Generation, 20162023 (USD Million)
Table 125 Germany: Market, By Platform, 20162023 (USD Million)
Table 126 Germany: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 127 Germany: Market, By Application, 20162023 (USD Million)
Table 128 Germany: Market, By End User, 20162023 (USD Million)
Table 129 Italy: Immunoassay Market, By Product & Service, 20162023 (USD Million)
Table 130 Italy: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 131 Italy: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 132 Italy: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 133 Italy: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 134 Italy: Elisa Market, By Generation, 20162023 (USD Million)
Table 135 Italy: Market, By Platform, 20162023 (USD Million)
Table 136 Italy: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 137 Italy: Market, By Application, 20162023 (USD Million)
Table 138 Italy: Immunoassay Market, By End User, 20162023 (USD Million)
Table 139 France: Market, By Product & Service, 20162023 (USD Million)
Table 140 France: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 141 France: Immunoassay Analyzers Market, By Type,20162023 (USD Million)
Table 142 France: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 143 France: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 144 France: Elisa Market, By Generation, 20162023 (USD Million)
Table 145 France: Market, By Platform, 20162023 (USD Million)
Table 146 France: Market, By Specimen Type, 20162023 (USD Million)
Table 147 France: Market, By Application, 20162023 (USD Million)
Table 148 France: Market, By End User, 20162023 (USD Million)
Table 149 Spain: Market, By Product & Service, 20162023 (USD Million)
Table 150 Spain: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 151 Spain: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 152 Spain: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 153 Spain: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 154 Spain: Elisa Market, By Generation, 20162023 (USD Million)
Table 155 Spain: Market, By Platform, 20162023 (USD Million)
Table 156 Spain: Market, By Specimen Type, 20162023 (USD Million)
Table 157 Spain: Market, By Application, 20162023 (USD Million)
Table 158 Spain: Market, By End User, 20162023 (USD Million)
Table 159 UK: Market, By Product & Service, 20162023 (USD Million)
Table 160 UK: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 161 UK: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 162 UK: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 163 UK: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 164 UK: Elisa Market, By Generation, 20162023 (USD Million)
Table 165 UK: Market, By Platform, 20162023 (USD Million)
Table 166 UK: Market, By Specimen Type, 20162023 (USD Million)
Table 167 UK: Immunoassay Market, By Application, 20162023 (USD Million)
Table 168 UK: Market, By End User, 20162023 (USD Million)
Table 169 Russia: Market, By Product & Service, 20162023 (USD Million)
Table 170 Russia: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 171 Russia: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 172 Russia: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 173 Russia: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 174 Russia: Elisa Market, By Generation, 20162023 (USD Million)
Table 175 Russia: Market, By Platform, 20162023 (USD Million)
Table 176 Russia: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 177 Russia: Market, By Application, 20162023 (USD Million)
Table 178 Russia: Immunoassay Market, By End User, 20162023 (USD Million)
Table 179 ROE: Market, By Product & Service, 20162023 (USD Million)
Table 180 ROE: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 181 ROE: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 182 ROE: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 183 ROE: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 184 ROE: Elisa Market, By Generation, 20162023 (USD Million)
Table 185 ROE: Market, By Platform, 20162023 (USD Million)
Table 186 ROE: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 187 ROE: Market, By Application, 20162023 (USD Million)
Table 188 ROE: Market, By End User, 20162023 (USD Million)
Table 189 Asia Pacific: Immunoassay Market, By Country, 20162023 (USD Million)
Table 190 Asia Pacific: Market, By Product & Service, 20162023 (USD Million)
Table 191 Asia Pacific: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 192 Asia Pacific: Immunoassay Analyzers Market, By Type,20162023 (USD Million)
Table 193 Asia Pacific: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 194 Asia Pacific: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 195 Asia Pacific: Elisa Market, By Generation, 20162023 (USD Million)
Table 196 Asia Pacific: Market, By Platform, 20162023 (USD Million)
Table 197 Asia Pacific: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 198 Asia Pacific: Market, By Application, 20162023 (USD Million)
Table 199 Asia Pacific: Immunoassay Market, By End User, 20162023 (USD Million)
Table 200 Japan: Market, By Product & Service, 20162023 (USD Million)
Table 201 Japan: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 202 Japan: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 203 Japan: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 204 Japan: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 205 Japan: Elisa Market, By Generation, 20162023 (USD Million)
Table 206 Japan: Market, By Platform, 20162023 (USD Million)
Table 207 Japan: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 208 Japan: Market, By Application, 20162023 (USD Million)
Table 209 Japan: Market, By End User, 20162023 (USD Million)
Table 210 China: Immunoassay Market, By Product & Service, 20162023 (USD Million)
Table 211 China: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 212 China: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 213 China: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 214 China: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 215 China: Elisa Market, By Generation, 20162023 (USD Million)
Table 216 China: Market, By Platform, 20162023 (USD Million)
Table 217 China: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 218 China: Market, By Application, 20162023 (USD Million)
Table 219 China: Immunoassay Market, By End User, 20162023 (USD Million)
Table 220 India: Market, By Product & Service, 20162023 (USD Million)
Table 221 India: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 222 India: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 223 India: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 224 India: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 225 India: Elisa Market, By Generation, 20162023 (USD Million)
Table 226 India: Market, By Platform, 20162023 (USD Million)
Table 227 India: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 228 India: Market, By Application, 20162023 (USD Million)
Table 229 India: Immunoassay Market, By End User, 20162023 (USD Million)
Table 230 Australia: Market, By Product & Service, 20162023 (USD Million)
Table 231 Australia: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 232 Australia: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 233 Australia: Immunoassay Analyzers Market, By Purchase Mode,20162023 (USD Million)
Table 234 Australia: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 235 Australia: Elisa Market, By Generation, 20162023 (USD Million)
Table 236 Australia: Market, By Platform, 20162023 (USD Million)
Table 237 Australia: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 238 Australia: Market, By Application, 20162023 (USD Million)
Table 239 Australia: Immunoassay Market, By End User, 20162023 (USD Million)
Table 240 South Korea: Market, By Product & Service, 20162023 (USD Million)
Table 241 South Korea: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 242 South Korea: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 243 South Korea: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 244 South Korea: Market, By Technology, 20162023 (USD Million)
Table 245 South Korea: Elisa Market, By Generation, 20162023 (USD Million)
Table 246 South Korea: Market, By Platform, 20162023 (USD Million)
Table 247 South Korea: Market, By Specimen Type, 20162023 (USD Million)
Table 248 South Korea: Immunoassay Market, By Application, 20162023 (USD Million)
Table 249 South Korea: Market, By End User, 20162023 (USD Million)
Table 250 Indonesia: Immunoassay Market, By Product & Service, 20162023 (USD Million)
Table 251 Indonesia: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 252 Indonesia: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 253 Indonesia: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 254 Indonesia: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 255 Indonesia: Elisa Market, By Generation, 20162023 (USD Million)
Table 256 Indonesia: Market, By Platform, 20162023 (USD Million)
Table 257 Indonesia: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 258 Indonesia: Market, By Application, 20162023 (USD Million)
Table 259 Indonesia: Market, By End User, 20162023 (USD Million)
Table 260 RoAPAC: Market, By Product & Service, 20162023 (USD Million)
Table 261 RoAPAC: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 262 RoAPAC: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 263 RoAPAC: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 264 RoAPAC: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 265 RoAPAC: Elisa Market, By Generation, 20162023 (USD Million)
Table 266 RoAPAC: Market, By Platform, 20162023 (USD Million)
Table 267 RoAPAC: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 268 RoAPAC: Market, By Application, 20162023 (USD Million)
Table 269 RoAPAC: Market, By End User, 20162023 (USD Million)
Table 270 Latin America: Immunoassay Market, By Product & Service, 20162023 (USD Million)
Table 271 Latin America: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 272 Latin America: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 273 Latin America: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 274 Latin America: Immunoassay Market, By Technology, 20162023 (USD Million)
Table 275 Latin America: Elisa Market, By Generation, 20162023 (USD Million)
Table 276 Latin America: Market, By Platform, 20162023 (USD Million)
Table 277 Latin America: Immunoassay Market, By Specimen Type, 20162023 (USD Million)
Table 278 Latin America: Market, By Application, 20162023 (USD Million)
Table 279 Latin America: Market, By End User, 20162023 (USD Million)
Table 280 MEA: Immunoassay Market, By Product & Service, 20162023 (USD Million)
Table 281 MEA: Immunoassay Reagents & Kits Market, By Type, 20162023 (USD Million)
Table 282 MEA: Immunoassay Analyzers Market, By Type, 20162023 (USD Million)
Table 283 MEA: Immunoassay Analyzers Market, By Purchase Mode, 20162023 (USD Million)
Table 284 MEA: Market, By Technology, 20162023 (USD Million)
Table 285 MEA: Elisa Market, By Generation, 20162023 (USD Million)
Table 286 MEA: Immunoassay Market, By Platform, 20162023 (USD Million)
Table 287 MEA: Market, By Specimen Type, 20162023 (USD Million)
Table 288 MEA: Immunoassay Market, By Application, 20162023 (USD Million)
Table 289 MEA: Market, By End User, 20162023 (USD Million)
Table 290 Product Launches, 20142017
Table 291 Partnerships, Collaborations, and Agreements, 20142017
Table 292 Expansions, 20142017
Table 293 Acquisitions, 20142017
List of Figures (50 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Immunoassay Market, By Product & Service, 2018 vs. 2023 (USD Billion)
Figure 7 Market, By Platform, 2018 vs. 2023 (USD Billion)
Figure 8 Immunoassay Market, By Technology, 2018 vs. 2023 (USD Billion)
Figure 9 Market, By Specimen Type, 2018 vs. 2023 (USD Billion)
Figure 10 Immunoassay Market, By Application, 2018 vs. 2023 (USD Billion)
Figure 11 Market, By End User, 2018 vs. 2023 (USD Billion)
Figure 12 Market, By Region, 2018 vs. 2023 (USD Billion)
Figure 13 Increasing Incidence of Chronic & Infectious Diseases and Technological Advancements in Immunoassay Instruments to Drive Market Growth During the Forecast Period
Figure 14 Chemiluminescence Immunoassays Accounted for the Largest Share of the Asia Pacific Immunoassay Market in 2017
Figure 15 Software & Services to Register the Highest Growth Rate During the Forecast Period
Figure 16 China & India to Witness the Highest Growth Rates in the Immunoassay Market From 2018 to 2023
Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Global Incidence of Diabetes, By Region, 2017 vs. 2045
Figure 19 Global Aging Population, By Region, 2017 vs. 2050 (Million)
Figure 20 Immunoassay Reagents & Kits Segment to Dominate the Market During the Forecast Period
Figure 21 Elisa Reagents & Kits Segment to Dominate the Immunoassay Reagents & Kits Market During the Forecast Period
Figure 22 Open-Ended Systems Segment to Dominate the Immunoassay Analyzers Market, By Type, During the Forecast Period
Figure 23 Rental Purchase Segment to Dominate the Immunoassay Analyzers Market, By Purchase Mode, During the Forecast Period
Figure 24 Chemiluminescence Immunoassays to Dominate the Market During the Forecast Period
Figure 25 Elisa Segment to Dominate the Market During the Forecast Period
Figure 26 Fourth-Generation & Above Elisa Segment to Dominate the Market During the Forecast Period
Figure 27 Blood Samples Segment to Dominate the Immunoassay Market, By Specimen Type, During the Forecast Period
Figure 28 Infectious Diseases Segment to Dominate the Market During the Forecast Period
Figure 29 Number of People Living With Hiv Globally, 2010 - 2016
Figure 30 Hospitals Segment to Dominate the Market in 2023
Figure 31 North America to Dominate the Global Immunoassay Market in 2018
Figure 32 North America: Market Snapshot
Figure 33 Asia Pacific: Immunoassay Market Snapshot
Figure 34 Market Share Analysis 2017
Figure 35 Roche: Company Snapshot (2017)
Figure 36 Abbott Laboratories: Company Snapshot (2017)
Figure 37 Siemens: Company Snapshot (2017)
Figure 38 Danaher: Company Snapshot (2017)
Figure 39 Diasorin: Company Snapshot (2016)
Figure 40 Sysmex: Company Snapshot (2017)
Figure 41 Biomιrieux: Company Snapshot (2016)
Figure 42 Qiagen: Company Snapshot (2016)
Figure 43 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 44 BD: Company Snapshot (2017)
Figure 45 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 46 Agilent Technologies: Company Snapshot (2017)
Figure 47 Perkinelmer: Company Snapshot (2017)
Figure 48 Quidel: Company Snapshot (2016)
Figure 49 Merck: Company Snapshot (2016)
Figure 50 Bio-Techne: Company Snapshot (2017)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Immunoassay Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Immunoassay Market